LEADER 02906nam 2200637 a 450 001 9910457781503321 005 20200520144314.0 010 $a1-283-32011-8 010 $a9786613320117 010 $a0-85724-716-6 035 $a(CKB)2550000000065241 035 $a(EBL)807427 035 $a(OCoLC)762192683 035 $a(SSID)ssj0000613250 035 $a(PQKBManifestationID)11406605 035 $a(PQKBTitleCode)TC0000613250 035 $a(PQKBWorkID)10584999 035 $a(PQKB)10584743 035 $a(MiAaPQ)EBC807427 035 $a(Au-PeEL)EBL807427 035 $a(CaPaEBR)ebr10512338 035 $a(CaONFJC)MIL332011 035 $a(EXLCZ)992550000000065241 100 $a20111206d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAccess to care and factors that impact access, patients as partners in care and changing roles of health providers$b[electronic resource] /$fedited by Jennie Jacobs Kronenfeld 205 $a1st ed. 210 $aBingley [England] $cEmerald Insight$d2011 215 $a1 online resource (310 p.) 225 1 $aResearch in the sociology of health care,$x0275-4959 ;$vv. 29 300 $aDescription based upon print version of record. 311 $a0-85724-715-8 320 $aIncludes bibliographical references. 327 $asection 1. Systems of health-care delivery and sociological issues -- section 2. Providers of care -- section 3. Patients as consumers of health-care services -- section 4. Health-care systems : modifications and reforms. 330 $aThis volume in the highly-regarded Research in the Sociology of Health Care series, deals with both macro-level system issues and micro-level issues involving access to care, factors that impact access, patients as partners in care and changing roles of health providers. It includes: examination of factors that impact access to care such as racial/ethnic, social, demographic and structural sources, discussion of changing patterns of care and changing patterns of interaction between patients and providers of care, and investigation of changing roles of health care providers within the health c 410 0$aResearch in the sociology of health care ;$vv. 29. 606 $aHealth services accessibility 606 $aMedical personnel and patient 606 $aMedical care 608 $aElectronic books. 615 0$aHealth services accessibility. 615 0$aMedical personnel and patient. 615 0$aMedical care. 676 $a362.1 701 $aKronenfeld$b Jennie J$0910415 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457781503321 996 $aAccess to care and factors that impact access, patients as partners in care and changing roles of health providers$92037693 997 $aUNINA LEADER 01121nam a2200289 i 4500 001 991000015779707536 005 20020503112322.0 008 980326s1971 us ||| | eng 020 $a0837155924 035 $ab10008950-39ule_inst 035 $aocm00008119$9ExL 040 $aDip.to Beni Culturali$bita 082 0 $a320.938502 100 1 $aFuks, Alexander$0152375 245 14$aThe ancestral constitution :$bfour studies in Athenian party politics at the end of the fifth century B.C. /$cby Alexander Fuks 260 $aWestport, Conn. :$bGreenwood Press,$c1971 300 $aix, 124 p. ;$c23 cm. 500 $aReprint of the 1953 ed. 500 $aIncludes bibliographical references 651 4$aAthens - Constitutional history 651 4$aAthens - Politics and government 907 $a.b10008950$b21-09-06$c31-05-02 912 $a991000015779707536 945 $aLE001 SG VI 65$g1$i2001000191505$lle001$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10011948$z31-05-02 996 $aAncestral constitution$9175706 997 $aUNISALENTO 998 $ale001$b01-01-98$cm$da $e-$feng$gus $h4$i1 LEADER 02563nam 2200673 a 450 001 9910822629203321 005 20240313143147.0 010 $a9783527651085 010 $a352765108X 010 $a9781299241206 010 $a1299241204 010 $a9783527651115 010 $a352765111X 010 $a9783527651108 010 $a3527651101 035 $a(CKB)2670000000337445 035 $a(EBL)1123660 035 $a(SSID)ssj0000990601 035 $a(PQKBManifestationID)11544702 035 $a(PQKBTitleCode)TC0000990601 035 $a(PQKBWorkID)10987429 035 $a(PQKB)10284427 035 $a(Au-PeEL)EBL1123660 035 $a(CaPaEBR)ebr10662582 035 $a(CaONFJC)MIL455370 035 $a(OCoLC)826637765 035 $a(MiAaPQ)EBC1123660 035 $a(PPN)178875457 035 $a(Perlego)999796 035 $a(EXLCZ)992670000000337445 100 $a20130306d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAnalogue-based drug discovery III /$fedited by Ja?nos Fischer, C. Robin Ganellin and David P. Rotella 205 $a1st ed. 210 $aWeinheim, Germany $cWiley-VCH$d2013 215 $a1 online resource (405 p.) 300 $aDescription based upon print version of record. 311 08$a9783527330737 311 08$a3527330739 320 $aIncludes bibliographical references and index. 327 $apt. 1. General aspects -- pt. 2. Drug classes -- pt. 3. Case studies. 330 $aMost drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtu 606 $aDrug development 615 0$aDrug development. 676 $a615.19 701 $aFischer$b Ja?nos$0881301 701 $aGanellin$b C. R$g(C. Robin)$0881302 701 $aRotella$b David P$01661495 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910822629203321 996 $aAnalogue-based drug discovery III$94017436 997 $aUNINA